

share
Ent-3-Oxokauran-17-Oic Acid CAS NO 151561-88-5
Unit Price:
CAS No.:151561-88-5
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Ent-3-Oxokauran-17-Oic Acid is a high-purity diterpenoid derivative of significant interest in advanced organic synthesis and pharmaceutical research. This compound serves as a crucial chiral building block and synthetic intermediate for the development of novel bioactive molecules. It is primarily utilized by research institutions and pharmaceutical companies engaged in the synthesis of complex natural products and the exploration of new therapeutic agents.
Application
- Pharmaceutical Intermediate: A key chiral precursor in the synthesis of novel drug candidates and complex natural product analogs.
- Organic Synthesis Building Block: Used in stereoselective reactions to construct complex diterpenoid frameworks and other intricate molecular architectures.
- Biochemical Research: Employed in studies investigating diterpenoid biosynthesis pathways, enzyme interactions, and structure-activity relationships (SAR).
- Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical and academic laboratories.
Basic Information
| Product Name | Ent-3-Oxokauran-17-Oic Acid |
| CAS No. | 151561-88-5 |
| Molecular Formula | C₂₀H₂₈O₃ |
| Molecular Weight | 316.44 g/mol |
| Synonyms | (-)-3-Oxokauran-17-oic acid; ent-3-Oxokauran-17-oic acid; 17-Kauran-3-one-17-carboxylic acid, ent-; (4aR,5S,6S,8aR)-5,6-Dimethyl-3-oxo-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalene-5-carboxylic acid; Kaurane-3-one-17-carboxylic acid, ent-; 3-Oxo-kauran-17-oic acid, ent-; 17-Carboxy-ent-kauran-3-one |
| EINECS | Contact for details |
Quality Control
Our Ent-3-Oxokauran-17-Oic Acid is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles, typically determined by advanced analytical techniques such as HPLC, GC, and NMR. We adhere to cGMP principles where applicable to support our clients' research and development needs.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The product should be kept under an inert atmosphere if long-term stability is required.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification (IR) | Conforms to structure |
| Identification (NMR) | Conforms to structure |
| Purity (HPLC) | ≥ 98.0% |
| Melting Point | Contact for details |
| Specific Rotation | Contact for details |
| Heavy Metals | < 10 ppm |
| Residual Solvents | Complies with ICH guidelines |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Parkeol CAS NO 514-45-4


(S)-(-)-Limonene CAS NO 5989-54-8


Terpinen-4-Ol CAS NO 562-74-3


Cedrene CAS NO 11028-42-5


β-Pinene CAS NO 127-91-3


3-Carene CAS NO 13466-78-9


Farnesene CAS NO 502-61-4


Glycyrrhizic Acid CAS NO 1405-86-3


Asiaticoside CAS NO 16830-15-2


Valerenic Acid CAS NO 3569-10-6


Asiatic Acid CAS NO 464-92-6


Zerumbone CAS NO 471-05-6


Cantharidin CAS NO 56-25-7


Madecassic Acid CAS NO 18449-41-7


Squalene CAS NO 111-02-4


D-(+)-Camphoric Acid CAS NO 124-83-4


Taraxerol CAS NO 127-22-0


Pimaric Acid CAS NO 127-27-5


1,2,3,4,4A,4B,5,6,7,9,10,10A-Dodecahydro-7-Isopropyl-1,4A-Dimethylphenanthren-1-Methanol CAS NO 127-36-6


Nopol CAS NO 128-50-7
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.




